Ascendis Pharma A/S - Common Stock (ASND)

CUSIP: 04351P101

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+1,192,784
Put/Call ratio
99%
SEC-reported price per share
$151.17
Number of holders
188
Value change
+$198,420,492
Number of buys
110
Open additional details 1 more signal available
Number of sells
81
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
62,915,156

Security key

04351P101

Report period

Q1 2024

Institutions

188

Top holders

10

Ownership snapshot

Top reported holders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $1,273,027,030 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $1.27B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
RA CAPITAL MANAGEMENT, L.P. $1.27B
Artisan Partners Limited Partnership $724.12M
FMR LLC $644.15M
WESTFIELD CAPITAL MANAGEMENT CO LP $507.66M
Janus Henderson Group Ltd. $503.1M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$1,273,027,030
10,107,400 shares
— 31 Dec 2023
Artisan Partners Limited Partnership
13F
Company
13F
—
denominator unverified
$724,115,141
5,749,227 shares
— 31 Dec 2023
FMR LLC
13F
Company
13F
—
denominator unverified
$644,154,776
5,114,369 shares
— 31 Dec 2023
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
13F
—
denominator unverified
$507,658,290
4,030,634 shares
— 31 Dec 2023
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$503,101,502
3,994,785 shares
— 31 Dec 2023
T. Rowe Price Investment Management, Inc.
13F
Company
13F
—
denominator unverified
$502,520,000
3,989,830 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
188
Shares
60,791,422
Rows available
188
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
188
Q1 2024 holders
188
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .